NYSE:GMED Globus Medical (GMED) Stock Price, News & Analysis → The A.I. story nobody is telling you (Read ASAP) (From TradeSmith) (Ad) Free GMED Stock Alerts $64.72 +0.36 (+0.56%) (As of 05/10/2024 ET) Add Compare Share Share Today's Range$63.75▼$64.9950-Day Range$49.79▼$64.7252-Week Range$43.38▼$65.74Volume1.79 million shsAverage Volume1.30 million shsMarket Capitalization$8.76 billionP/E Ratio101.13Dividend YieldN/APrice Target$66.50 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Get Globus Medical alerts: Email Address Globus Medical MarketRank™ Stock AnalysisAnalyst RatingModerate Buy2.55 Rating ScoreUpside/Downside2.8% Upside$66.50 Price TargetShort InterestBearish6.64% of Shares Sold ShortDividend StrengthN/ASustainability-0.93Upright™ Environmental ScoreNews Sentiment0.71Based on 53 Articles This WeekInsider TradingSelling Shares$1.85 M Sold Last QuarterProj. Earnings Growth21.93%From $2.69 to $3.28 Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.4.52 out of 5 starsMedical Sector96th out of 921 stocksSurgical & Medical Instruments Industry14th out of 98 stocks 2.3 Analyst's Opinion Consensus RatingGlobus Medical has received a consensus rating of Moderate Buy. The company's average rating score is 2.55, and is based on 6 buy ratings, 5 hold ratings, and no sell ratings.Amount of Analyst CoverageGlobus Medical has been the subject of 6 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Globus Medical's stock forecast and price target. Previous Next 1.0 Short Interest Percentage of Shares Shorted6.64% of the outstanding shares of Globus Medical have been sold short.Short Interest Ratio / Days to CoverGlobus Medical has a short interest ratio ("days to cover") of 8.Change versus previous monthShort interest in Globus Medical has recently increased by 19.71%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldGlobus Medical does not currently pay a dividend.Dividend GrowthGlobus Medical does not have a long track record of dividend growth. Previous Next 4.1 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreGlobus Medical has received a 57.33% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is mostly driven by its "Neurostimulators", "Synthetic bone grafts", "Artificial joints", and "Robotic surgery systems" products. See details.Environmental SustainabilityThe Environmental Impact score for Globus Medical is -0.93. Previous Next 3.2 News and Social Media Coverage News SentimentGlobus Medical has a news sentiment score of 0.71. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.52 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 53 news articles for Globus Medical this week, compared to 5 articles on an average week.Search InterestOnly 1 people have searched for GMED on MarketBeat in the last 30 days. This is a decrease of -67% compared to the previous 30 days.MarketBeat Follows4 people have added Globus Medical to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days. Previous Next 4.2 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Globus Medical insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $1,850,574.00 in company stock.Percentage Held by Insiders24.30% of the stock of Globus Medical is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions95.16% of the stock of Globus Medical is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Globus Medical's insider trading history. Previous Next 3.1 Earnings and Valuation Earnings GrowthEarnings for Globus Medical are expected to grow by 21.93% in the coming year, from $2.69 to $3.28 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Globus Medical is 55.32, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 132.94.Price to Earnings Ratio vs. SectorThe P/E ratio of Globus Medical is 55.32, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 119.77.Price to Earnings Growth RatioGlobus Medical has a PEG Ratio of 1.48. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioGlobus Medical has a P/B Ratio of 2.21. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Globus Medical's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Crypto 101 MediaThe Crypto 9-5 Escape PlanA brand-new guide from the host of one of the world's largest cryptocurrency podcasts lays out an action plan that could help you retire quickly and comfortably in today's crypto market.Click here to get instant access to the guide About Globus Medical Stock (NYSE:GMED)Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative and congenital conditions, deformity, tumors, and trauma injuries; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. It also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, the company distributes human cell, tissue, and cellular and tissue-based products. It sells its products through direct or distributor sales representatives, as well as hip and knee products through independent sales agents. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.Read More GMED Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart GMED Stock News HeadlinesMay 11, 2024 | americanbankingnews.comPiper Sandler Raises Globus Medical (NYSE:GMED) Price Target to $60.00May 11, 2024 | americanbankingnews.comGlobus Medical (NYSE:GMED) Price Target Raised to $70.00May 11, 2024 | Crypto Swap Profits (Ad)Claim Your Complimentary Bitcoin RewardMany have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.May 10, 2024 | americanbankingnews.comGlobus Medical (NYSE:GMED) PT Raised to $63.00 at BTIG ResearchMay 10, 2024 | americanbankingnews.comGlobus Medical, Inc. (NYSE:GMED) Expected to Post FY2026 Earnings of $3.77 Per ShareMay 10, 2024 | americanbankingnews.comGlobus Medical (NYSE:GMED) Stock Rating Reaffirmed by Needham & Company LLCMay 10, 2024 | americanbankingnews.comAnalysts Issue Forecasts for Globus Medical, Inc.'s Q2 2024 Earnings (NYSE:GMED)May 10, 2024 | msn.comGlobus Medical Reports Strong Sales Growth Post-NuVasive Merger Despite Quarterly Net LossMay 11, 2024 | Crypto Swap Profits (Ad)Claim Your Complimentary Bitcoin RewardMany have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.May 9, 2024 | msn.comGlobal Partners LP (NYSE:GLP) Q1 2024 Earnings Call TranscriptMay 9, 2024 | benzinga.comKey Takeaways From Globus Medical Analyst RatingsMay 9, 2024 | americanbankingnews.comFY2025 EPS Estimates for Globus Medical, Inc. Increased by Zacks Research (NYSE:GMED)May 9, 2024 | finance.yahoo.comThree Growth Companies With High Insider Ownership And 36% Earnings GrowthMay 9, 2024 | americanbankingnews.comGlobus Medical (NYSE:GMED) Hits New 1-Year High on Better-Than-Expected EarningsMay 8, 2024 | marketwatch.comGlobus Medical Shares Rise 22% on Raised FY Outlook, 1Q Revenue BeatMay 8, 2024 | markets.businessinsider.comStrong Buy: Globus Medical’s Robust Performance and Strategic Growth OutlookMay 8, 2024 | markets.businessinsider.comGlobus Medical Up 23% As Q1 Results Beat Street; Raises FY OutlookMay 8, 2024 | msn.comGlobus Medical Shares Race Higher After Better-Than-Expected Q1 ResultsMay 8, 2024 | finance.yahoo.comGlobus Medical, Inc. (NYSE:GMED) Q1 2024 Earnings Call TranscriptMay 8, 2024 | msn.comGMED Stock Earnings: Globus Medical Beats EPS, Beats Revenue for Q1 2024May 8, 2024 | fool.comGlobus Medical (GMED) Q1 2024 Earnings Call TranscriptMay 7, 2024 | msn.comGlobus Medical up 11% on guidance boost, Q1 resultsMay 7, 2024 | globenewswire.comGlobus Medical Reports First Quarter 2024 ResultsMay 7, 2024 | markets.businessinsider.comGlobus Medical A earnings preview: what to expectMay 7, 2024 | americanbankingnews.comGlobus Medical, Inc. (NYSE:GMED) Given Consensus Recommendation of "Moderate Buy" by BrokeragesMay 5, 2024 | americanbankingnews.comGlobus Medical (GMED) Scheduled to Post Earnings on TuesdayApril 29, 2024 | nasdaq.comGMED Quantitative Stock Analysis - Benjamin GrahamSee More Headlines Receive GMED Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Globus Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/07/2024Today5/10/2024Next Earnings (Estimated)8/01/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Surgical & medical instruments Sub-IndustryHealth Care Equipment Current SymbolNYSE:GMED CUSIP37957720 CIK1237831 Webwww.globusmedical.com Phone(610) 930-1800Fax610-930-2042Employees5,000Year FoundedN/APrice Target and Rating Average Stock Price Target$66.50 High Stock Price Target$85.00 Low Stock Price Target$53.00 Potential Upside/Downside+2.8%Consensus RatingModerate Buy Rating Score (0-4)2.55 Research Coverage11 Analysts Profitability EPS (Most Recent Fiscal Year)$1.17 Trailing P/E Ratio55.32 Forward P/E Ratio24.06 P/E Growth1.53Net Income$122.87 million Net Margins7.83% Pretax Margin10.55% Return on Equity8.82% Return on Assets7.20% Debt Debt-to-Equity Ratio0.10 Current Ratio4.88 Quick Ratio2.72 Sales & Book Value Annual Sales$1.57 billion Price / Sales5.59 Cash Flow$4.49 per share Price / Cash Flow14.40 Book Value$29.32 per share Price / Book2.21Miscellaneous Outstanding Shares135,372,000Free Float102,477,000Market Cap$8.76 billion OptionableOptionable Beta1.11 7 Stocks to Buy And Hold ForeverClick the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free Report Key ExecutivesMr. David C. Paul (Age 57)Co-Founder & Executive Chairman Comp: $1.09MMr. Daniel T. Scavilla (Age 59)President, CEO & Director Comp: $1.37MMr. Keith W. Pfeil (Age 44)CFO & COO Comp: $675.89kMs. Kelly G. Huller Esq. (Age 52)Senior VP, General Counsel & Secretary Comp: $543.24kMr. Brian J. Kearns (Age 57)Senior Vice President of Business Development & Investor Relations Key CompetitorsTeleflexNYSE:TFXIntegra LifeSciencesNASDAQ:IARTAlphatecNASDAQ:ATECInsuletNASDAQ:PODDBaxter InternationalNYSE:BAXView All CompetitorsInsiders & InstitutionsVanguard Group Inc.Sold 323,041 shares on 5/10/2024Ownership: 8.092%Nicolet Advisory Services LLCBought 5,765 shares on 5/10/2024Ownership: 0.004%Orion Portfolio Solutions LLCBought 1,837 shares on 5/9/2024Ownership: 0.020%Blair William & Co. ILSold 1,558 shares on 5/9/2024Ownership: 0.010%Mitsubishi UFJ Asset Management Co. Ltd.Sold 535 shares on 5/9/2024Ownership: 0.008%View All Insider TransactionsView All Institutional Transactions GMED Stock Analysis - Frequently Asked Questions Should I buy or sell Globus Medical stock right now? 11 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Globus Medical in the last twelve months. There are currently 5 hold ratings and 6 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" GMED shares. View GMED analyst ratings or view top-rated stocks. What is Globus Medical's stock price target for 2024? 11 Wall Street analysts have issued 1-year price targets for Globus Medical's shares. Their GMED share price targets range from $53.00 to $85.00. On average, they expect the company's share price to reach $66.50 in the next year. This suggests a possible upside of 2.8% from the stock's current price. View analysts price targets for GMED or view top-rated stocks among Wall Street analysts. How have GMED shares performed in 2024? Globus Medical's stock was trading at $53.29 at the start of the year. Since then, GMED stock has increased by 21.4% and is now trading at $64.72. View the best growth stocks for 2024 here. Are investors shorting Globus Medical? Globus Medical saw a increase in short interest during the month of April. As of April 30th, there was short interest totaling 8,990,000 shares, an increase of 19.7% from the April 15th total of 7,510,000 shares. Based on an average daily volume of 1,120,000 shares, the days-to-cover ratio is presently 8.0 days. View Globus Medical's Short Interest. When is Globus Medical's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, August 1st 2024. View our GMED earnings forecast. How were Globus Medical's earnings last quarter? Globus Medical, Inc. (NYSE:GMED) released its quarterly earnings data on Tuesday, May, 7th. The medical device company reported $0.72 EPS for the quarter, topping the consensus estimate of $0.55 by $0.17. The medical device company had revenue of $606.67 million for the quarter, compared to the consensus estimate of $586.82 million. Globus Medical had a net margin of 7.83% and a trailing twelve-month return on equity of 8.82%. The company's revenue was up 119.3% compared to the same quarter last year. During the same period in the previous year, the business earned $0.53 earnings per share. What ETFs hold Globus Medical's stock? ETFs with the largest weight of Globus Medical (NYSE:GMED) stock in their portfolio include Motley Fool Mid-Cap Growth ETF (TMFM), MFAM Small-Cap Growth ETF (MFMS), Motley Fool Small-Cap Growth ETF (TMFS), First Trust Nasdaq Lux Digital Health Solutions ETF (EKG), First Trust Indxx Medical Devices ETF (MDEV) and SPDR S&P Health Care Equipment ETF (XHE).iShares U.S. Medical Devices ETF (IHI). What guidance has Globus Medical issued on next quarter's earnings? Globus Medical issued an update on its FY 2024 earnings guidance on Wednesday, May, 8th. The company provided EPS guidance of 2.750-2.850 for the period, compared to the consensus EPS estimate of 2.690. The company issued revenue guidance of $2.5 billion-$2.5 billion, compared to the consensus revenue estimate of $2.5 billion. What is David Demski's approval rating as Globus Medical's CEO? 47 employees have rated Globus Medical Chief Executive Officer David Demski on Glassdoor.com. David Demski has an approval rating of 61% among the company's employees. This puts David Demski in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies. What other stocks do shareholders of Globus Medical own? Based on aggregate information from My MarketBeat watchlists, some companies that other Globus Medical investors own include NVIDIA (NVDA), Shopify (SHOP), CrowdStrike (CRWD), Okta (OKTA), Trade Desk (TTD), Block (SQ), Tesla (TSLA), Teladoc Health (TDOC), Zoom Video Communications (ZM) and Mastercard (MA). Who are Globus Medical's major shareholders? Globus Medical's stock is owned by many different retail and institutional investors. Top institutional investors include Vanguard Group Inc. (8.09%), Bank of New York Mellon Corp (2.23%), William Blair Investment Management LLC (1.65%), Geneva Capital Management LLC (1.16%), Vaughan Nelson Investment Management L.P. (0.71%) and Global Alpha Capital Management Ltd. (0.69%). Insiders that own company stock include Dan Lemaitre, Daniel T Scavilla, Daniel T Scavilla, David D Davidar, James R Tobin, Keith W Pfeil, Keith W Pfeil, Kelly Huller and Leslie V Norwalk. View institutional ownership trends. How do I buy shares of Globus Medical? Shares of GMED stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NYSE:GMED) was last updated on 5/11/2024 by MarketBeat.com Staff From Our PartnersThe Crypto 9-5 Escape PlanCrypto 101 MediaDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressGlobal crypto currency reset (41 major banks signed up)Stansberry ResearchHow Biden has already won 2024Porter & CompanyRSVP: Charles Payne’s Cash Flow WorkshopUnstoppable ProsperityThe “Next Bitcoin”? 10 CENT Crypto Set to ExplodeTrue Market InsidersThe ONE AI Stock to own now. (It’s not Nvidia.)Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Globus Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.